Jenny® is the world's first modular intensive care system for intensive care units and emergency services and is suitable for all patient groups.

Jenny currently has 3 modules: ventilator, patient monitor and defibrillator.

Jenny's modular design not only enables a better workflow, but also a significant reduction in costs as several stand-alone devices are replaced.

50% of the costs of each stand-alone device are in the "medical PC", which is required for each device again and again.

Since Jenny covers the entire patient population, no high-priced "niche" products are required.

After all, Jenny's hybrid ventilator replaces an entire ventilator "family."

The overall target market for Jenny has estimated sales of $ 10 billion per year. A market share of only 0.5% would represent a $ 50 million deal.

This should be achieved by 2023.

The patents for Jenny belong to the medical technology company MS Westfalia based in Troisdorf in the Cologne / Bonn region.

After the surge in sales and capacities as a result of the COVID-19 pandemic, the company is looking for investors to secure its expansion.

A strategic investor with international sales experience in the medical technology sector is particularly welcome.